SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OCGT again

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stock Puppy who wrote (73)11/7/1996 4:37:00 PM
From: Jack Ucci   of 283
 
I agree security on the net will be a fact of life but I don't think it will impede the increasing use of the net, even for medical applications such as ocgt's system.

Two other thoughts. If we believe that revenue numbers will play a significant role in how ocgt's stock fares, then one has to be impressed with the breadth of ocgt's announcements in the past year. And a look at their 50 week chart in the context that the most recent qtr ER was less than 5 weeks ago suggests that the stock is at a testing point in this 1.21-1.31 range. If it drops below it we are looking at 1.00 nearterm, and if it holds together with something really positive(or some brokerage house recommendation) then we could see it at 1.875 or slightly better before the next ER announcement.

I don't see any announcements about numbers coming from the company, but I do think it is likely we will see more 'deal' announcements. If only they could get some favorable publicity or notice, say in Investor Business Daily or an article or mention in Business Week etc, then we might see signicant price movement. The latter is not likely however.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext